Replication-selective microbiological agents: fighting cancer with targeted germ warfare

被引：47

作者：

Kirn, DH ^{[1
]}

机构：

[1] Hammersmith Hosp, Imperial Coll Sch Med, Program Viral & Genet Therapy Canc, Imperial Canc Res Fund,Mol Oncol Unit, London W12 0NN, England

来源：

JOURNAL OF CLINICAL INVESTIGATION | 2000年 / 105卷 / 07期

关键词：

D O I：

10.1172/JCI9761

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

[No abstract available]

引用

页码：837 / 839

页数：3

共 15 条

[1]

ASADA T, 1974, CANCER, V34, P1907, DOI 10.1002/1097-0142(197412)34:6<1907::AID-CNCR2820340609>3.0.CO

[2]

2-4

[3]

Coley W.B., 1893, AM J MED SCI, V105, P487, DOI DOI 10.1097/00000441-189305000-00001

[4]

Coley WB, 1911, SURG GYNECOL OBSTET, V13, P174

[5]

Dock G, 1904, AM J MED SCI, V127, P563

[6] ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents [J].

Heise, C ;

SampsonJohannes, A ;

Williams, A ;

McCormick, F ;

VonHoff, DD ;

Kirn, DH .

NATURE MEDICINE, 1997, 3 (06) :639-645

[7]

KIRN D, 1998, P AN M AM SOC CLIN, V17, pA391

[8]

KIRN DH, 1999, P AN M AM SOC CLIN, V18, P1505

[9]

Lattime EC, 1996, SEMIN ONCOL, V23, P88

[10] ATTENUATED MULTI-MUTATED HERPES-SIMPLEX VIRUS-1 FOR THE TREATMENT OF MALIGNANT GLIOMAS [J].

MINETA, T ;

RABKIN, SD ;

YAZAKI, T ;

HUNTER, WD ;

MARTUZA, RL .

NATURE MEDICINE, 1995, 1 (09) :938-943

← 1 2 →